Sanofi’s innovation hub, which employs 2,500 people, is based in Cambridge, Massachusetts. Swiftwater, Pennsylvania contains the company’s vaccine production sites, whilst Framingham ...

Making up for losses in federal funding with private dollars would not be easy. In NIH funding alone, Massachusetts entities brought in nearly $3.4 billion in fiscal 2024.

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ...

On January 15, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility’s bioreactor, the vessel used to grow organisms and cells.

FDA has issued a warning letter to Sanofi summarizing “significant deviations” from current good manufacturing practice (CGMP) for APIs based on inspections conducted from June 12 to July 9, 2024, at ...

The initial inspection in Framingham ran from June 12 to July 9, 2024, and yielded a Form 483, which the FDA says Sanofi responded to by late July. The letter itself, which marks an escalation ...

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...

Framingham has become a hub for life science development, and that status was further cemented when Framingham Public Schools was awarded a grant of $159,617 on Monday to help further life science ...

Marybeth O'Brien, director of curriculum, instruction and assessment for Framingham Public Schools, speaks during Monday's press conference at Sanofi, July 22, 2024.